Relationship of serum imatinib trough level and response in CML patients: Long term follow-up
Abdalla Awidi(University of Jordan), Lena Marie(King Hussein Cancer Center), Ahmad Magablah(University of Jordan), Eyad Arafat(Ministry of Health), Ayed O. Ayed(Florida Cancer Specialists & Research Institute), Mohammad Dweiri(Ministry of Health), Mohammad Ramahi(Ministry of Health), Mohammad Bishtawi(Ministry of Health), Razan Mefleh(University of Jordan), Nazzal Bsoul(University of Jordan)
Cited by 39
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
|Blood|2024|132